Clinical Trials for Patients

Clinical Trials for Patients

What is a Clinical Trial?

When a drug company or a device company comes up with a new drug or product, this product is extensively tested. The test results are then submitted to the Food and Drug Administration (FDA). It evaluates the results before approval for general use. During this testing process, the company uses centers known for their quality and prestige. These centers give the drug or use the device on their patients. They collect information on efficacy (how effective the new drug or device is). They also collect information on safety (is the new drug or device safe). This is called a Clinical Trial.

Why should you participate in a Clinical Trial?

  1. A clinical trial may give you access to a treatment not yet available to the general public.
  2. You help in the development of new knowledge and treatments for patients in general.
  3. You receive evaluation and treatment at no cost to you.
  4. You are paid for your time and inconvenience.

Is a Clinical Trial safe?

No guarantees can be made that any given Clinical Trial is safe. However, trials by reputable centers such as ours make every effort to maintain safety. The Clinical Trial is first reviewed and approved by an Institutional Review Board. This happens before any patients are enrolled. You are given a detailed Informed Consent. You review it before you agree to participate. You may withdraw your participation or leave the study at any time. Generally, we make every effort to make sure that any harm to you (and we have never had any significant safety issue in doing this for 22 years) is taken care of by the company developed by the new drug or product.

Do you have any Clinical Trial going on at this time?

Currently we are conducting the following Clinical Trials:

  1. Narcolepsy Clinical Trial: Patients ages 18-50, with Narcolepsy. This study is looking at the effect of a new medicine on sleepiness in patients with Narcolepsy who have access to their previous test results confirming Narcolepsy. The study lasts about 5 weeks, with three sleep testing stays (overnight and the next day) with us. Patients may get active medicine or placebo. We pay $930 for the subject’s time and expenses upon completing the study.
  2. Narcolepsy Clinical Trial with open label: Patients age 18-65, with Narcolepsy. This study looks at the effect of a new medicine on sleepiness in patients with Narcolepsy who have access to their previous test results confirming Narcolepsy. The study lasts about 7 weeks, with 6 office visits. Patients may get active medicine of placebo. We pay $960 for the subject’s time and expenses upon completing the study. At the end of the study, patients may join an open label extension study during which they get the medicine for sure for six months.

Clinical trials come and go, and they fill up fast. Please click here to see if we are currently recruiting for any trials.

How do I participate?

Call our office at 586-254-0707, or fill out a request for us to contact you.

What is the Best Pillow?

What is the Best Pillow? Patients often ask us, “What is the best pillow?” Patients also ask whether there is a pillow to use with CPAP, or a pillow that treats snoring and sleep apnea. According to Consumer Reports, the best pillow is Coop Home Goods Premium Adjustable Loft, followed closely by Sleep Number ComfortFit…

Amphetamines should not be stimulants of first choice

Amphetamines should not be stimulants of first choice Amphetamines in DEA Schedule 2 (AdderallR, DexedrineR, VyvanseR) are the most commonly prescribed stimulants in the USA. These amphetamines should not be the stimulants of first choice. However, amphetamine use increased 2.5 fold from 2006 to 2016. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261411/) Stimulant medicines (amphetamines, methylphenidate, modafinil, armodafinil, solriamfetol) are generally…

Obstructive Sleep Apnea Almost Doubles the Risk of Sudden Death

Obstructive Sleep Apnea Almost Doubles the Risk of Sudden Death A large analysis of 22 studies with 42099 subjects showed that obstructive sleep apnea (OSA) almost doubles the risk of sudden death. The risk of sudden death of any cause was increased by 74%, and the risk of cardiovascular deaths by 95%. The authors looked…

Schedule An Appointment Today

44344 Dequindre Rd Suite 360
Sterling Heights, MI 48314
click here for directions